Literature DB >> 23104049

Geographical distribution of patients visiting a health information exchange in New York City.

Arit Onyile1, Sandip R Vaidya, Gilad Kuperman, Jason S Shapiro.   

Abstract

OBJECTIVE: For a health information exchange (HIE) organization to succeed in any given region, it is important to understand the optimal catchment area for the patient population it is serving. The objective of this analysis was to understand the geographical distribution of the patients being served by one HIE organization in New York City (NYC).
MATERIALS AND METHODS: Patient demographic data were obtained from the New York Clinical Information Exchange (NYCLIX), a regional health information organization (RHIO) representing most of the major medical centers in the borough of Manhattan in NYC. Patients' home address zip codes were used to create a research dataset with aggregate counts of patients by US county and international standards organization country. Times Square was designated as the geographical center point of the RHIO for distance calculations.
RESULTS: Most patients (87.7%) live within a 30 mile radius from Times Square and there was a precipitous drop off of patients visiting RHIO-affiliated facilities at distances greater than 100 miles. 43.6% of patients visiting NYCLIX facilities were from the other NYC boroughs rather than from Manhattan itself (31.9%). DISCUSSION: Most patients who seek care at members of NYCLIX live within a well-defined area and a clear decrease in patients visiting NYCLIX sites with distance was identified. Understanding the geographical distribution of patients visiting the large medical centers in the RHIO can inform the RHIO's planning as it looks to add new participant organizations in the surrounding geographical area.

Entities:  

Keywords:  Health Information Exchange (HIE); Regional Health Information Organization (RHIO); cluster analysis; patient geographical distribution; regional health planning

Mesh:

Year:  2012        PMID: 23104049      PMCID: PMC3715355          DOI: 10.1136/amiajnl-2012-001217

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


Background and significance

Through the Health Information Technology for Economic and Clinical Health (HITECH) Act, which is part of the American Recovery and Reinvestment Act of 20091–3 the US government has taken an unprecedented step towards promoting interoperability through secure electronic health information systems nationwide, including the allocation of US$19.2 billion towards the adoption and meaningful use of health information technology (HIT)1 and US$564 million for state-level health information exchanges (HIE).4 The goal of HITECH is to improve the quality of health for Americans through the adoption and meaningful use of HIT.5 In order for this to be accomplished successfully, and for the full potential of HIT to be realized, an increased emphasis is placed on interoperability between healthcare providers and provider organizations, as evidenced in the meaningful use stage 2 proposed rule.6 Along with directed exchange initiatives and consumer-based HIE efforts, state-level HIE funded by HITECH will help improve interoperability and move towards a nationwide HIE network.7–9 Before the federally funded state-level HIE programme, and often serving as its building blocks, regional health information organizations (RHIO) bring together multiple stakeholders within a given geographical area, managing governance, policy development and operational issues as they create HIE at a regional level. Although there has been some regular study of the 255 functioning HIE currently in existence nationwide,10 to date there is a paucity of analysis in the literature describing the geographical distribution of patients within a RHIO in a metropolitan area. We hypothesize that a RHIO in a major metropolitan area would have a concentration of patients visiting its participant organizations from within the city, and then a ‘penumbra’ effect with patients visiting from outlying boroughs and suburbs, with a likely inflection point in visits per capita as distance from the center of the RHIO increased. The area in this ‘penumbra’ or ‘white space’9 may contain provider organizations and other potential stakeholders that are not part of the RHIO. For one RHIO in New York City (NYC), this study aims to identify the ‘catchment’ area of the RHIO by identifying how the proportion of patients visiting the RHIO varies with distance and other geographical factors. Identifying this catchment area and understanding the geographical distribution of patients will aid in the strategic planning process when seeking to align with new partner organizations in the region. The objectives of this study were: (1) to identify the proportion of patients in the HIE within the primary service area of the participant organizations of the RHIO; (2) to identify the proportion of patients from the immediately contiguous geographical areas, nationwide and internationally; (3) to determine if there was an inflection point that indicated the primary area of the coverage of the RHIO, thereby defining the ideal catchment area for the RHIO.

Materials and methods

Setting

At the time of the study (2011), there were four functioning RHIO in NYC, one in each of the four largest boroughs: Manhattan, Queens, Brooklyn and The Bronx. A fifth RHIO covered Long Island, a region adjacent to NYC, and a sixth RHIO covered Westchester County, also adjacent to NYC. The New York Clinical Information Exchange (NYCLIX) was a Manhattan-based RHIO, which built an operational, secure HIE available to authorized hospitals and other healthcare providers in the NYC metropolitan area. (At the time of this study, NYCLIX was an independent HIE. As of April 2012, NYCLIX merged with the Long-Island-based RHIO Lipix to form a new organization, Healthix Inc.) NYCLIX was a collaboration among ambulatory physician groups, long-term care facilities, a Medicaid managed care plan, the nation's largest home healthcare provider and academic medical centers that serve as major referral centers with a total of 7503 inpatient beds, 341 065 annual inpatient discharge and 540 854 annual emergency department visits (see table 1). NYCLIX began operations in 2007 and its stakeholders were in Manhattan, Brooklyn and Staten Island.
Table 1

Data related to NYCLIX member hospitals during the study period

Beds13Inpatient discharges14
Sites in Manhattan
Site 189941186
Site 2117159063
Site 381445404
Site 4117850675
Site 587931546
Site 650529333
Site 752319903
Sites in other boroughs of NYC
Site 871441819
Site 937619057
Site 1021211258
Totals7503341065

NYC, New York City; NYCLIX, New York Clinical Information Exchange.

Data related to NYCLIX member hospitals during the study period NYC, New York City; NYCLIX, New York Clinical Information Exchange.

Datasets

In order to understand the geographical distribution of patients visiting a NYCLIX facility, we used data from the NYCLIX master patient iIndex (MPI). The MPI is a database that maintains an identifier for every unique patient registered within the HIE. The MPI receives demographic information from each participant organization and includes patient address and zip code and/or country name. In the analysis, when the patient had address information from multiple sources, the most recent source was used. NYCLIX began to operate functionally in March 2009 and contains information on patients who visited a NYCLIX participant since that time. The NYCLIX operations team had access to full US zip codes and mapped the most current zip code for each unique patient to the appropriate US county using an internal SAS dataset, SASHELP.zipcode. Times Square was designated as the NYCLIX geographical center point. The operations team then calculated the distance from each zip code to Times Square. Any patient who did not have a five or nine-digit zip code was excluded from the study. The final dataset that was delivered to the research team included aggregate counts of patients by US county and international standards organization (ISO) country code and distance from Times Square. This dataset was imported into SAS V.9.2 for further analysis. The protocol for this study was reviewed by the Mount Sinai Program for the Protection of Human Subjects and was issued a determination letter stating it is not human subjects research.

Statistical methods

The number of unique patients visiting a NYCLIX facility was the unit of measure. US Census Bureau data were used for denominators in calculating adjusted rates for specific geographical regions (number of patients from county divided by the number of people living in the county). For each county, the rate of people visiting a NYCLIX facility was calculated by dividing the number of people who had visited a NYCLIX site by the total number of people in the county (2010 census counts). Charts, graphs and maps using aggregate counts and rates were created for counties, states and geographical regions within the USA and ISO countries (see figures 1-3 and tables 1-4). We identified the ISO countries in the research dataset and countries that could not be mapped were manually coded by the research team whenever possible. EpiInfo V.3.5.3 was used to create state and regional maps. Data from the US Census Bureau was used in running spatial regression analyses. Spatial regressions were performed using SatScan V.9.1.1 released 9 March 2011 to identify spatial clusters at the state and county level and determine the likelihood or relative risks (RR) that residents in these spatial clusters would visit a NYCLIX facility by comparing the NYCLIX data to census data. A cluster county was defined as a county that had a RR greater than 1 (which is considered statistically significant). Residents from those counties are more likely to visit a NYCLIX facility when compared to residents from other counties. The following surrounding tri-state counties were excluded for the spatial regression: New York: NYC, Nassau, Suffolk, Westchester; New Jersey: Bergen, Essex, Hudson, Middlesex, Monmouth; and Connecticut: Fairfield and New Haven. Doing this allowed us to look for cluster counties not in the immediate NYCLIX geographical area. The spatial regressions helped examine the relationship between the likelihood of visiting a NYCLIX facility (dependent variable) and geographical/spatial location (independent variable).

Results

As of 27 May 2011 there were 4 006 605 unique patients who had visited a NYCLIX facility or provider. Of these, 0.7% (26 589) patients were excluded from the analysis for having an invalid (non-five or nine-digit) zip code leaving 3 980 016 for analysis. Our analysis plan consisted of analyses grouped into three geographical categories: immediate NYCLIX geographical area, nationwide and internationally.

Tri-state (New York, New Jersey, Connecticut)

New York, New Jersey and Connecticut represented 3 867 738 patients out of a total of 3 980 016 in the NYCLIX dataset (97.2% out of the 3 980 016 of those in NYCLIX; with a visit rate of 12.1 per 100 patients living in those states based on 2010 census data) (table 2). Table 3 depicts the incremental increase in the number of patients comprising the total patients in NYCLIX with distance. The rate of patients visiting NYCLIX per capita dropped precipitously with distance from 24.3 per 100 within 30 miles to 0.42 per 100 at 100 miles (figure 1); 3 863 854 patients were in counties within 100 miles from the NYCLIX geographical center, Times Square, representing 97.1% of the total patients in NYCLIX. Within the range of 0–100 miles, the average rate of patients visiting a NYCLIX facility was 8.7 per 100; 87.7% of patients in NYCLIX (3 487 499) live within a 30 mile radius from Times Square and the inflection point, after which the rate of patients visiting NYCLIX remains below one per 100, was at approximately 80 miles from Times Square (see figure 1).
Table 2

Distribution of NYCLIX patients within the tri-state (New York, New Jersey, Connecticut) region

Geographical regionNo. of unique patientsCensus 2010 countRate (per 100)Relative riskp Value
NYC (boroughs/counties)
Manhattan1268916163130677.8
Richmond (Staten Island)28975149335158.7
Kings (Brooklyn)718727258465227.8
Bronx366655140225026.1
Queens36065023197715.5
NYC total3004699634353647.4
New York (counties)
NYC*3004699634353647.4
Ulster4743118082126.214.4<0.05
Rockland4178330183913.814.4<0.05
Westchester*12641296149913.1
Suffolk*13086415212118.6
Duchess230722924607.914.4<0.05
Nassau*10674713647457.8
Orange296063830847.714.4<0.05
Putnam6434993656.514.4<0.05
Sullivan4259753105.714.4<0.05
NY state total35361361957773018.1
New Jersey (counties)
Hudson*543596006579
Bergen*748569007668.3
Morris211894891124.314.4<0.05
Monmouth*242146455833.8
Essex*288157691563.7
Passaic15035493430314.4<0.05
Union141395298862.714.4<0.05
Middlesex*200767948572.5
Somerset77393289302.414.4<0.05
Sussex36621509082.414.4<0.05
NJ state total29250687328113.3
Connecticut (counties)
Fairfield*304559082633.4
New Haven*35148505870.4
CT state total3909635269370.3
Tri-state total38677383183747812.1

*Indicates excluded from the cluster analysis.

CT, Connecticut; NJ, New Jersey; NY, New York; NYC, New York City; NYCLIX, New York Clinical Information Exchange.

Table 3

Incremental increase in patients visiting NYCLIX with distance from primary address

AreaNo. of patients% Total patients
NYC*300469975.5
Additional patients from New Jersey state2925067.3
Additional patients from Long Island†2376116.0
Additional patients from New York state‡1674144.2
Additional patients from Westchester county1264123.2
Additional patients from the rest of the USA1122782.8
Additional patients from Connecticut state390961.0
Total3980016100.0

*Includes Manhattan, Brooklyn, Bronx, Queens and Staten Island.

†Includes Nassau, New York and Suffolk, New York counties.

‡Excludes NYC, Westchester, Nassau and Suffolk counties.

NYC, New York City; NYCLIX, New York Clinical Information Exchange.

Figure 1

Percentage of patients visiting a New York Clinical Information Exchange (NYCLIX) facility per capita by distance from patient's primary address. The rate of patients visiting a NYCLIX facility at incremental distances from the set NYCLIX geographical center, Times Square. The rate for miles 0–30 was 24.3 rate per 100, but is not displayed for purposes of scale on the graph. A polynomial curve was fitted to illustrate the distance at which the visit rate flattens out.

Distribution of NYCLIX patients within the tri-state (New York, New Jersey, Connecticut) region *Indicates excluded from the cluster analysis. CT, Connecticut; NJ, New Jersey; NY, New York; NYC, New York City; NYCLIX, New York Clinical Information Exchange. Incremental increase in patients visiting NYCLIX with distance from primary address *Includes Manhattan, Brooklyn, Bronx, Queens and Staten Island. †Includes Nassau, New York and Suffolk, New York counties. ‡Excludes NYC, Westchester, Nassau and Suffolk counties. NYC, New York City; NYCLIX, New York Clinical Information Exchange. Percentage of patients visiting a New York Clinical Information Exchange (NYCLIX) facility per capita by distance from patient's primary address. The rate of patients visiting a NYCLIX facility at incremental distances from the set NYCLIX geographical center, Times Square. The rate for miles 0–30 was 24.3 rate per 100, but is not displayed for purposes of scale on the graph. A polynomial curve was fitted to illustrate the distance at which the visit rate flattens out.

New York City

A total of 3 004 699 patients resided in NYC (Bronx, Kings (Brooklyn), Manhattan, Queens and Richmond (Staten Island) counties), representing 75.5% of patients in NYCLIX and 35.6 rate per 100 people in this geographical area (table 2). When combined, the absolute count of patients visiting NYCLIX sites from the four NYC outer boroughs excluding Manhattan was 1 735 783 (43.6% of NYCLIX patients). This is larger than the number of patients visiting NYCLIX sites from Manhattan itself, 1 268 916 (31.9% of NYCLIX patients) (figure 2), although the rates of patients visiting a NYCLIX site per capita were lower in the other boroughs (25.5 rate per 100) when compared to Manhattan (77.8 rate per 100). Within NYC, when excluding Manhattan, Brooklyn had the highest absolute count of patients, 718 727 (18.1% of NYCLIX patients; 27.8 rate per 100). When excluding NYC and taking into account 2010 census population counts, the areas surrounding NYC (Long Island: Nassau, Suffolk; and Westchester counties) had the highest rate of patients visiting NYCLIX facilities, 9.5 rate per 100 (figure 3). A total of 364 023 patients (9.1% of NYCLIX patients; 9.5 rate per 100) visited a NYCLIX facility from these regions. The regions surrounding the NYC metropolitan area were identified as spatial clusters. The residents in these regions had a greater likelihood of visiting a NYCLIX facility than not visiting a NYCLIX facility when excluding NYC.
Figure 2

New York City (NYC) geographical distribution of New York Clinical Information Exchange (NYCLIX) patients. The absolute count of patients visiting NYCLIX sites from the four NYC outer boroughs combined, excluding Manhattan, was larger (1 735 783) than the number of patients visiting NYCLIX sites from Manhattan itself (1 268 916), although the rate of patients visiting a NYCLIX site per capita was higher in Manhattan (77.8 rate per 100), compared to outer boroughs (25.5 rate per 100).

Figure 3

Visit per capita rate of New York Clinical Information Exchange patients by county per 100 persons. Cluster counties are counties that had a population with a relative risk greater than 1 when the following counties were excluded: New York: New York City, Nassau, Suffolk, Westchester; New Jersey: Bergen, Essex, Hudson, Middlesex, Monmouth; Connecticut: Fairfield and New Haven.

New York City (NYC) geographical distribution of New York Clinical Information Exchange (NYCLIX) patients. The absolute count of patients visiting NYCLIX sites from the four NYC outer boroughs combined, excluding Manhattan, was larger (1 735 783) than the number of patients visiting NYCLIX sites from Manhattan itself (1 268 916), although the rate of patients visiting a NYCLIX site per capita was higher in Manhattan (77.8 rate per 100), compared to outer boroughs (25.5 rate per 100). Visit per capita rate of New York Clinical Information Exchange patients by county per 100 persons. Cluster counties are counties that had a population with a relative risk greater than 1 when the following counties were excluded: New York: New York City, Nassau, Suffolk, Westchester; New Jersey: Bergen, Essex, Hudson, Middlesex, Monmouth; Connecticut: Fairfield and New Haven. The New York downstate region, made up of NYC, Long Island, Hudson Valley and Catskills regions of New York state had the highest rate of patients visiting a NYCLIX facility (3 526 611; 88.6% of NYCLIX patients; 24.8 rate per 100).

Surrounding tri-state counties (New York, New Jersey, Connecticut)

The surrounding tri-state NYC counties were identified as being New York: Nassau, Suffolk, Westchester; New Jersey: Bergen, Essex, Hudson, Middlesex, Monmouth; and Connecticut: Fairfield and New Haven. These counties accounted for 600 312 patients in our dataset who visited a NYCLIX provider (15.1% of NYCLIX patients; 6.3 rate per 100) compared to 262 727 patients from the remaining counties within the tri-state region (New York, New Jersey, Connecticut) (6.6% of NYCLIX patients; 1.8 rate per 100).

Cluster analysis

When excluding NYC and the nearby surrounding counties the following counties were identified as cluster counties in New York: Duchess, Orange, Putnam, Rockland, Sullivan, Ulster; and New Jersey: Morris, Somerset, Sussex and Union. The RR for patients living within these counties to visit a NYCLIX site compared to the rest of the state is 14.40 (p<0.05) when excluding the following counties: New York: NYC, Nassau, Suffolk, Westchester; New Jersey: Bergen, Essex, Hudson, Middlesex and Monmouth; and Connecticut: Fairfield and New Haven (see table 2).

Nationwide analysis

All 50 states, District of Columbia and United State territories had representation in our dataset. As of April 2011, as per the US Census Bureau there were 41 357 US zip codes and 1931 US counties. The NYCLIX patient population had representation in 77.7% (1500) of all US counties and 39.7% (16 401) of all US zip codes and 890 (97.4%) of the 914 three-digit zip code prefixes that currently exist in the USA.

International analysis

As per the MAP.NAMES SAS dataset, there are 239 unique ISO countries worldwide and the NYCLIX patient population spans across 57 ISO countries (excluding the USA); 1739 patients (0.04% of NYCLIX patients) came from overseas (see table 4).
Table 4

International geographic distribution of NYCLIX patients (excluding USA).

ISO countryNo. of patients% Total international patients
UK24013.8
Canada1438.2
Dominican Republic965.5
Brazil925.3
China804.6
France804.6
Other ISO countries100858.0
Total1739100.0

ISO, international standard organization; NYCLIX, New York Clinical Information Exchange.

International geographic distribution of NYCLIX patients (excluding USA). ISO, international standard organization; NYCLIX, New York Clinical Information Exchange.

Discussion

NYCLIX has representation in all 50 US states, four US territories and 57 ISO countries. With the diversity of the New York metropolitan area it is not surprising that a RHIO situated in this region has such a wide representation of patients. As shown in figure 3 there are a set of concentric circles around NYC depicting the decreasing numbers of patients visiting NYCLIX with distance. Most patients come from the regions surrounding NYC. Although our analysis does not show anything we did not expect, it confirms our initial hypothesis. There is a relationship between a patient's permanent address and distance traveled to see a healthcare provider. Also as predicted, the concentration of patients visiting the RHIO sites per capita decreased with distance, but not in a linear fashion, with an inflection point in the penumbra of the RHIO, seen in figure 1 between 60 and 100 miles from the center of the RHIO. This information has aided the RHIO in strategic planning when deciding which stakeholder organizations to approach when it comes to expansion, and similar approaches may be helpful to other RHIO across the country. One surprising result was that the outer boroughs combined, Bronx, Brooklyn (Kings County), Staten Island (Richmond) and Queens, have a larger absolute count of patients visiting NYCLIX than Manhattan, where most of the RHIO provider organizations are based. This suggests that the behavior of patients seeking healthcare is fluid. Patients move throughout the local region for healthcare. Currently, there are six RHIO covering NYC, Long Island and Westchester, which appear to have taken the problem of fragmentation of patient information that existed at the provider organization level, and aggregated it up to the level of the RHIO. While aggregation of data at this higher level of the overall healthcare system is an improvement, it still amounts to silos of data given the level of patient fluidity shown here. This suggests a need for inter-RHIO interoperability perhaps using the nationwide health information network's3 query-based exchange model11 that relies on aggregate data being accessible and in turn provides data access for unplanned care and when a patient travels across provider organizations. Without this level of interoperability, it will be difficult or impossible for any of the current individual RHIO to reach a critical mass of patients or data in order to provide comprehensive higher level services such as care coordination or quality measurement. The NYC metropolitan area has a mono-centric city pattern of commuting, with many workers commuting to a central point, Manhattan, but residing in suburban areas.12 Most patients reside within 60 miles from Times Square. Although there is an overall negative relationship between distance and the likelihood of visiting a NYCLIX provider, there are some peaks and valleys between 30–100 miles from Times Square. At distances greater than 100 miles from Times Square the rate of visits per capita is very small. This may indicate that some NYCLIX patients include commuters into Manhattan who choose to seek care close to their place of work rather than where they reside, or may suggest that even though some of the participants in NYCLIX are major referral centers, that the fraction of patients that constitute referrals from a distance is not that significant. Cluster counties are identified as regions where residents have a higher likelihood of visiting a NYCLIX site. We ran a Poisson regression to identify cluster counties. As we excluded counties close to NYC the counties in the next most distal region became cluster counties. We did not find any cluster counties as outliers at large distances from NYC, which we had considered a possibility. Our findings suggest that the likelihood of visiting a NYCLIX provider is primarily dependent on distance. Furthermore, even within a dense metropolitan area with large academic medical centers and specialists, patients are likely to seek healthcare as a function of distance from where they reside or work.

Limitations

In calculating the rates, the numerator and denominator came from different datasets. The numerator was a dynamic number representing the cumulative total of patients who have visited a NYCLIX site or provider from March 2009 to May 2011, and some patients may not have been living at the listed home address at the time the census data were collected. The denominator was a static number representing the census count at a specific point in time in 2010. There is thus a possibility that the rates calculated do not reflect the true rate as of 2011. Fifteen out of the 57 country entries found in the NYCLIX dataset did not match to an ISO country name in the MAP.NAMES SAS dataset. These countries had to be manually mapped by the research team. Finally, the MAP.NAMES SAS dataset, used to identify ISO countries, was released in December 2008 and may not accurately reflect the current number of ISO countries as of the date of the analysis.

Conclusions

This study shows that patients are highly mobile and visit providers across city, county, state and national lines. Under HITECH there will be a transition from paper medical records to electronic medical records. RHIO and HIE offer the opportunity for healthcare data to be shared among providers and facilities across city, county and state jurisdictions, more accurately reflecting the way in which patients actually access healthcare. Although NYC represents the largest metropolitan area in the country, and it is not clear that these results will generalize to other regions, similar analyses may aid other regions in determining how best to spread scarce resources when deciding where the geographical boundaries of an HIE organization should be drawn.
  6 in total

1.  Health care and the American Recovery and Reinvestment Act.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2009-02-17       Impact factor: 91.245

2.  Launching HITECH.

Authors:  David Blumenthal
Journal:  N Engl J Med       Date:  2009-12-30       Impact factor: 91.245

3.  Health-information exchange: why are we doing it, and what are we doing?

Authors:  Gilad J Kuperman
Journal:  J Am Med Inform Assoc       Date:  2011-06-14       Impact factor: 4.497

4.  Information infrastructure for consumer health: a health information exchange stakeholder study.

Authors:  Judah Thornewill; Alan F Dowling; Barbara A Cox; Robert J Esterhay
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

5.  Medicare and Medicaid programs; electronic health record incentive program--stage 2. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2012-09-04

6.  From the Office of the National Coordinator: the strategy for advancing the exchange of health information.

Authors:  Claudia Williams; Farzad Mostashari; Kory Mertz; Emily Hogin; Parmeeth Atwal
Journal:  Health Aff (Millwood)       Date:  2012-03       Impact factor: 6.301

  6 in total
  9 in total

1.  Professional and geographical network effects on healthcare information exchange growth: does proximity really matter?

Authors:  Niam Yaraghi; Anna Ye Du; Raj Sharman; Ram D Gopal; R Ramesh; Ranjit Singh; Gurdev Singh
Journal:  J Am Med Inform Assoc       Date:  2013-11-28       Impact factor: 4.497

2.  Predictive Assessment of Cancer Center Catchment Area from Electronic Health Records.

Authors:  Luca Salmasi; Enrico Capobianco
Journal:  Front Public Health       Date:  2017-11-16

3.  Patterns of health information exchange strategies underlying health information technologies capabilities building.

Authors:  Placide Poba-Nzaou; Sylvestre Uwizeyemungu; Mamadou Dakouo; Anicet Tchibozo; Bocar Mboup
Journal:  Health Syst (Basingstoke)       Date:  2021-07-16

4.  Using a health information exchange system for imaging information: patterns and predictors.

Authors:  Joshua R Vest; Zachary M Grinspan; Lisa M Kern; Thomas R Campion; Rainu Kaushal
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

5.  Catchment area analysis using bayesian regression modeling.

Authors:  Aobo Wang; David C Wheeler
Journal:  Cancer Inform       Date:  2015-04-19

6.  Health Information Exchange Use (1990-2015): A Systematic Review.

Authors:  Emily Beth Devine; Annette M Totten; Paul Gorman; Karen B Eden; Steven Kassakian; Susan Woods; Monica Daeges; Miranda Pappas; Marian McDonagh; William R Hersh
Journal:  EGEMS (Wash DC)       Date:  2017-12-07

7.  Application of Bayesian Regression for the Identification of a Catchment Area for Cancer Cases in Dogs and Cats.

Authors:  José Manuel Díaz Cao; Michael S Kent; Ruwini Rupasinghe; Beatriz Martínez-López
Journal:  Front Vet Sci       Date:  2022-07-25

8.  People with epilepsy who use multiple hospitals; prevalence and associated factors assessed via a health information exchange.

Authors:  Zachary M Grinspan; Erika L Abramson; Samprit Banerjee; Lisa M Kern; Rainu Kaushal; Jason S Shapiro
Journal:  Epilepsia       Date:  2014-03-05       Impact factor: 6.740

9.  Changing the research landscape: the New York City Clinical Data Research Network.

Authors:  Rainu Kaushal; George Hripcsak; Deborah D Ascheim; Toby Bloom; Thomas R Campion; Arthur L Caplan; Brian P Currie; Thomas Check; Emme Levin Deland; Marc N Gourevitch; Raffaella Hart; Carol R Horowitz; Isaac Kastenbaum; Arthur Aaron Levin; Alexander F H Low; Paul Meissner; Parsa Mirhaji; Harold A Pincus; Charles Scaglione; Donna Shelley; Jonathan N Tobin
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.